Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children

• Patrick Georges Cech ,

  Contributed equally to this work with: Patrick Georges Cech, Thomas Aebi

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Thomas Aebi ,

  Contributed equally to this work with: Patrick Georges Cech, Thomas Aebi

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland, Bagamoyo Research and Training Unit, Ifakara Health Institute, Dar es Salaam, Tanzania

  ⨯
• Mwanajaa Shomari Abdallah,

  Affiliation Bagamoyo Research and Training Unit, Ifakara Health Institute, Dar es Salaam, Tanzania

  ⨯
• Maxmillian Mpina,

  Affiliation Bagamoyo Research and Training Unit, Ifakara Health Institute, Dar es Salaam, Tanzania

  ⨯
• Ester Barnabas Machunda,

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Nicole Westerfeld,

  Affiliation Pevion Biotech AG, Ittigen bei Bern, Switzerland

  ⨯
• Sabine Alexandra Stoffel,

  Affiliation Pevion Biotech AG, Ittigen bei Bern, Switzerland

  ⨯
• Rinaldo Zurbriggen,

  Affiliation Pevion Biotech AG, Ittigen bei Bern, Switzerland

  ⨯
• Gerd Pluschke,

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Marcel Tanner,

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Claudia Daubenberger,

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland

  ⨯
• Blaise Genton ,

  * E-mail: blaise.genton@unibas.ch

  Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland, Infectious Disease Service and Travel Clinic, Lausanne University Hospital, Lausanne, Switzerland

  ⨯
• Salim Abdulla

  Affiliation Bagamoyo Research and Training Unit, Ifakara Health Institute, Dar es Salaam, Tanzania

  ⨯